Nabeel Ahmad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nabeel Ahmad has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Saad Bin Toufeeq
Lahore General Hospital
4 shared publications - Neykzad Wadeer
Department of General Surgery, CURE International Hospital, Kabul, Afghanistan
2 shared publications Ahmad Sama
Lahore General Hospital Ameer‐Ud‐Din Medical College Lahore Pakistan
1 shared publication- Ali Bin Toufeeq
Lahore General Hospital International School of Medicine/International University of Kyrgyzstan Bishkek Kyrgyzstan
1 shared publication Ali Toufeeq
Lahore General Hospital
1 shared publicationAmmara Arshad
Lahore General Hospital
1 shared publication
Latest Publications
- Open Access
- 22 May 2026
- Published by Pakistan Society of Gastroenterology and GI Endoscopy in Pakistan journal of Gastroenterology
- Vol. 42 (1) , 883-889
Aprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Background: Cyclical vomiting syndrome (CVS) is a disorder of gut–brain interaction characterized by recurrent, stereotyped episodes of intense nausea and vomiting with return to baseline in between. Pediatric CVS often leads to frequent hospitalizations, comorbidities, and poor quality of life. Standard abortive therapies include 5-HT₃ antagonists (e.g. ondansetron) and triptans, while prophylaxis may involve cyproheptadine or amitriptyline. Aprepitant, an oral neurokinin-1 (NK1) receptor antagonist approved for chemotherapy-induced nausea, is increasingly used off-label in refractory pediatric CVS. Its efficacy and safety in this setting remain unclear. Methods: We conducted a PRISMA-style systematic review of studies reporting on aprepitant in pediatric CVS. We searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library from inception to 15 January 2025 for any study (randomized trials, cohorts, case series, reports) of aprepitant in children (<18) with CVS. Two reviewers independently screened records, extracted data, and assessed risk of bias using standard tools. Outcomes were patient-reported response (episode frequency/intensity), healthcare utilization (episodes/year, admissions), and adverse events. Due to heterogeneity, results are summarized narratively. Results: No randomized controlled trials were identified. Evidence consisted of one retrospective controlled cohort study, one retrospective single-center case series, and one case report, with mixed findings and overall low certainty. We included three studies (total n≈1817): one large retrospective controlled cohort (Thavamani et al. 2024; n=1775, 96 received aprepitant), one single-center retrospective series (Cristofori et al. 2014; n=41), and one single-patient case report (Nivatsi et al. 2021). In the Thavamani cohort, aprepitant use as an abortive agent did not reduce 7-day readmission rates (17% vs. 16%, p=0.91), although those receiving aprepitant had more severe initial illness (longer stay: 5 vs. 3 days; higher costs: \$11,790 vs. \$6,380). Cristofori et al. reported that 81% of children on prophylactic aprepitant and 76% on abortive aprepitant had complete or partial clinical response at 12 months. Both subgroups showed significant reductions in CVS episodes per year, hospital admissions, episode duration, and improved school attendance. Side effects occurred only in the prophylactic group (31% of children) and were mild (hiccups, fatigue, appetite increase, headache, migraine). The single case (13-year-old girl) had failed standard therapy but experienced complete cessation of vomiting after starting brief oral aprepitant at prodrome. Limitations: All evidence is from observational or anecdotal reports with high risk of bias. The cohort used administrative data without randomized assignment, and the retrospective series lacked a control group. Adverse events were sparsely reported. Conclusion: Preliminary evidence suggests aprepitant can reduce symptoms in refractory pediatric CVS and is well tolerated, but a large multicenter RCT is needed. Current data are insufficient to endorse routine use; aprepitant may be considered in severe, treatment-refractory cases under specialist care.
- 22 May 2026
- Published by Pakistan Society of Gastroenterology and GI Endoscopy in Pakistan journal of Gastroenterology
- Vol. 42 (1) , 883-889
Open AccessAprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Background: Cyclical vomiting syndrome (CVS) is a disorder of gut–brain interaction characterized by recurrent, stereotyped episodes of intense nausea and vomiting with return to baseline in between. Pediatric CVS often leads to frequent hospitalizations, comorbidities, and poor quality of life. Standard abortive therapies include 5-HT₃ antagonists (e.g. ondansetron) and triptans, while prophylaxis may involve cyproheptadine or amitriptyline. Aprepitant, an oral neurokinin-1 (NK1) receptor antagonist approved for chemotherapy-induced nausea, is increasingly used off-label in refractory pediatric CVS. Its efficacy and safety in this setting remain unclear. Methods: We conducted a PRISMA-style systematic review of studies reporting on aprepitant in pediatric CVS. We searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library from inception to 15 January 2025 for any study (randomized trials, cohorts, case series, reports) of aprepitant in children (<18) with CVS. Two reviewers independently screened records, extracted data, and assessed risk of bias using standard tools. Outcomes were patient-reported response (episode frequency/intensity), healthcare utilization (episodes/year, admissions), and adverse events. Due to heterogeneity, results are summarized narratively. Results: No randomized controlled trials were identified. Evidence consisted of one retrospective controlled cohort study, one retrospective single-center case series, and one case report, with mixed findings and overall low certainty. We included three studies (total n≈1817): one large retrospective controlled cohort (Thavamani et al. 2024; n=1775, 96 received aprepitant), one single-center retrospective series (Cristofori et al. 2014; n=41), and one single-patient case report (Nivatsi et al. 2021). In the Thavamani cohort, aprepitant use as an abortive agent did not reduce 7-day readmission rates (17% vs. 16%, p=0.91), although those receiving aprepitant had more severe initial illness (longer stay: 5 vs. 3 days; higher costs: \$11,790 vs. \$6,380). Cristofori et al. reported that 81% of children on prophylactic aprepitant and 76% on abortive aprepitant had complete or partial clinical response at 12 months. Both subgroups showed significant reductions in CVS episodes per year, hospital admissions, episode duration, and improved school attendance. Side effects occurred only in the prophylactic group (31% of children) and were mild (hiccups, fatigue, appetite increase, headache, migraine). The single case (13-year-old girl) had failed standard therapy but experienced complete cessation of vomiting after starting brief oral aprepitant at prodrome. Limitations: All evidence is from observational or anecdotal reports with high risk of bias. The cohort used administrative data without randomized assignment, and the retrospective series lacked a control group. Adverse events were sparsely reported. Conclusion: Preliminary evidence suggests aprepitant can reduce symptoms in refractory pediatric CVS and is well tolerated, but a large multicenter RCT is needed. Current data are insufficient to endorse routine use; aprepitant may be considered in severe, treatment-refractory cases under specialist care.
- Open Access
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Secondary Dengue Infection Presenting With Kawasaki Disease–Like Features: A Diagnostic Dilemma in a 12‐Year‐Old Girl
In dengue‐endemic regions, prolonged fever with mucocutaneous findings may represent classical Kawasaki disease (KD), dengue‐associated KD‐like inflammation, or true concomitant disease. When KD cannot be confidently excluded, timely IVIG administration may be justified to prevent coronary complications. Structured follow‐up including serial echocardiography remains essential.
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Open AccessSecondary Dengue Infection Presenting With Kawasaki Disease–Like Features: A Diagnostic Dilemma in a 12‐Year‐Old Girl
In dengue‐endemic regions, prolonged fever with mucocutaneous findings may represent classical Kawasaki disease (KD), dengue‐associated KD‐like inflammation, or true concomitant disease. When KD cannot be confidently excluded, timely IVIG administration may be justified to prevent coronary complications. Structured follow‐up including serial echocardiography remains essential.
- Open Access
- 28 March 2026
- Published by Health Services Academy in Pakistan Journal of Public Health
- Vol. 16 (1)
One Patient, One Attendant: An Overlooked Necessity for Better Patient Care in Pakistan’s Tertiary Care Hospitals
Massive footfall of patients in tertiary care hospitals across Pakistan has become a chronic challenge. These hospitals are overwhelmed not only by patients but also by large groups of attendants accompanying each patient, turning wards into congested, chaotic spaces compromising patient care. An article of DAWN mentions about Non-cooperative behaviour of attendants, who insisted on staying with their patients, also contributed to the overcrowding (1). Although, “one patient, one attendant” policies are being displayed in most of the wards, but enforcement of this very policy remains almost nonexistent. Most patients are accompanied by several attendants who crowd the bedside, restrict staff movement, and interfere during rounds and procedures. One of the major precipitating factor in Pakistani doctors’ burnout and over exhaustion in an already over worked environment is the unwarranted and unnecessary presence of a patient’s attendants in, sometimes, a critical life threatening scenario where either you manage the attendants or save a life. Such encounters lead to arguments, delays, and sometimes violence (2), further highlighting the urgent need for strict policy enforcement. The influx of unnecessary attendants disrupts doctors’ and nurses’ workflow, increases infection risk and compromises patient privacy and adds to hospital waste and resource strain.
- 28 March 2026
- Published by Health Services Academy in Pakistan Journal of Public Health
- Vol. 16 (1)
Open AccessOne Patient, One Attendant: An Overlooked Necessity for Better Patient Care in Pakistan’s Tertiary Care Hospitals
Massive footfall of patients in tertiary care hospitals across Pakistan has become a chronic challenge. These hospitals are overwhelmed not only by patients but also by large groups of attendants accompanying each patient, turning wards into congested, chaotic spaces compromising patient care. An article of DAWN mentions about Non-cooperative behaviour of attendants, who insisted on staying with their patients, also contributed to the overcrowding (1). Although, “one patient, one attendant” policies are being displayed in most of the wards, but enforcement of this very policy remains almost nonexistent. Most patients are accompanied by several attendants who crowd the bedside, restrict staff movement, and interfere during rounds and procedures. One of the major precipitating factor in Pakistani doctors’ burnout and over exhaustion in an already over worked environment is the unwarranted and unnecessary presence of a patient’s attendants in, sometimes, a critical life threatening scenario where either you manage the attendants or save a life. Such encounters lead to arguments, delays, and sometimes violence (2), further highlighting the urgent need for strict policy enforcement. The influx of unnecessary attendants disrupts doctors’ and nurses’ workflow, increases infection risk and compromises patient privacy and adds to hospital waste and resource strain.
- 27 January 2026
- Published by Medip Academy in International Journal of Contemporary Pediatrics
- Vol. 13 (2) , 365-366
From awareness to accountability: strengthening pediatric antibiotic stewardship in low-resource outpatient setting
In pediatric outpatient departments, antibiotic prescriptions are frequently empirical and often used for self-limiting viral illnesses, fueling antimicrobial resistance (AMR). While awareness programs have improved knowledge among clinicians and caregivers, sustainable behavioral change remains limited without accountability mechanisms. This letter highlights the critical role of pediatric antimicrobial stewardship programs (ASPs), emphasizing audit-feedback interventions that have shown up to a 23% reduction in unnecessary antibiotic initiation and a 17% reduction in broad-spectrum antibiotic selection. In low-resource outpatient settings, the lack of point-of-care diagnostics perpetuates empirical prescribing. Integrating affordable diagnostic tools, enforcing stewardship policies, and adopting the WHO AWaRe framework within regional healthcare systems can strengthen accountability and optimize antibiotic use in children.
- 27 January 2026
- Published by Medip Academy in International Journal of Contemporary Pediatrics
- Vol. 13 (2) , 365-366
From awareness to accountability: strengthening pediatric antibiotic stewardship in low-resource outpatient setting
In pediatric outpatient departments, antibiotic prescriptions are frequently empirical and often used for self-limiting viral illnesses, fueling antimicrobial resistance (AMR). While awareness programs have improved knowledge among clinicians and caregivers, sustainable behavioral change remains limited without accountability mechanisms. This letter highlights the critical role of pediatric antimicrobial stewardship programs (ASPs), emphasizing audit-feedback interventions that have shown up to a 23% reduction in unnecessary antibiotic initiation and a 17% reduction in broad-spectrum antibiotic selection. In low-resource outpatient settings, the lack of point-of-care diagnostics perpetuates empirical prescribing. Integrating affordable diagnostic tools, enforcing stewardship policies, and adopting the WHO AWaRe framework within regional healthcare systems can strengthen accountability and optimize antibiotic use in children.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1)
Obstructive Cholestasis in IL12RB1 Deficiency: A Case Report of an Unusual Hepatobiliary Presentation in Mendelian Susceptibility to Mycobacterial Disease
While IL12RB1 deficiency is classically associated with susceptibility to mycobacterial and Salmonella infections, its clinical spectrum may be broader than currently documented literature. Timely recognition of atypical pleiotropic presentations can contribute to earlier diagnosis, more tailored interventions, and eventually better patient outcome. However, current literature lacks reports of hepatic involvement such as biliary strictures or intrahepatic cholestasis in IL12RB1 ‐deficient patients. This case exemplifies the diagnostic odyssey of a child with a rare genetic anomaly manifesting as two seemingly unrelated pathophysiologies; the diagnosis was established through genetic testing after exhaustive evaluation excluded infectious, metabolic, and autoimmune etiologies. This case raises the possibility of atypical hepatobiliary manifestations associated with IL12RB1 deficiency. Early genetic testing should be integrated into the diagnostic pathways with undiagnosed cholestasis, and clinicians should remain vigilant for systemic manifestations beyond the classical infectious profile.
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1)
Open AccessObstructive Cholestasis in IL12RB1 Deficiency: A Case Report of an Unusual Hepatobiliary Presentation in Mendelian Susceptibility to Mycobacterial Disease
While IL12RB1 deficiency is classically associated with susceptibility to mycobacterial and Salmonella infections, its clinical spectrum may be broader than currently documented literature. Timely recognition of atypical pleiotropic presentations can contribute to earlier diagnosis, more tailored interventions, and eventually better patient outcome. However, current literature lacks reports of hepatic involvement such as biliary strictures or intrahepatic cholestasis in IL12RB1 ‐deficient patients. This case exemplifies the diagnostic odyssey of a child with a rare genetic anomaly manifesting as two seemingly unrelated pathophysiologies; the diagnosis was established through genetic testing after exhaustive evaluation excluded infectious, metabolic, and autoimmune etiologies. This case raises the possibility of atypical hepatobiliary manifestations associated with IL12RB1 deficiency. Early genetic testing should be integrated into the diagnostic pathways with undiagnosed cholestasis, and clinicians should remain vigilant for systemic manifestations beyond the classical infectious profile.
- Open Access
- 22 December 2025
- Published by Wiley
DENGUE FEVER MIMICKING CLINICAL FEATURES OF KD IMPROVED WITH IVIG IN A 12 YEAR OLD GIRL: A DIAGNOSTIC PITFALL
- 22 December 2025
- Published by Wiley
Open AccessDENGUE FEVER MIMICKING CLINICAL FEATURES OF KD IMPROVED WITH IVIG IN A 12 YEAR OLD GIRL: A DIAGNOSTIC PITFALL
- Open Access
- 5 August 2025
- Published by Springer Nature in Research Square
Comparing the prognostic accuracy of the Neonatal Sequential organ failure assessment (nSOFA) score and the Score for Neonatal Acute Physiology Perinatal Extension-II (SNAPPE-II) score in neonates with sepsis.
Objective: This study compares the prognostic accuracy of the Neonatal Sequential Organ Failure Assessment (nSOFA) score and the Score for Neonatal Acute Physiology Perinatal Extension-II (SNAPPE-II) in predicting mortality among neonates with sepsis. Methods: A retrospective cohort analysis was conducted on 175 septic neonates admitted to the NICU. nSOFA and SNAPPE-II scores were calculated and analyzed using logistic regression and AUROC curves. Results: Both scores were significantly higher among non-survivors (p < 0.001). SNAPPE-II demonstrated a slightly superior predictive ability (AUC: 0.893) compared to nSOFA (AUC: 0.861). A moderate positive correlation (r = 0.514, p < 0.001) was observed between the two scores. Logistic regression confirmed both as independent predictors of mortality. Conclusion: While SNAPPE-II marginally outperformed nSOFA in predictive accuracy, nSOFA’s simplicity and real-time applicability render it highly valuable, particularly in resource-limited settings. Both tools offer robust risk stratification and can guide early, targeted intervention in neonatal sepsis.
- 5 August 2025
- Published by Springer Nature in Research Square
Open AccessComparing the prognostic accuracy of the Neonatal Sequential organ failure assessment (nSOFA) score and the Score for Neonatal Acute Physiology Perinatal Extension-II (SNAPPE-II) score in neonates with sepsis.
Objective: This study compares the prognostic accuracy of the Neonatal Sequential Organ Failure Assessment (nSOFA) score and the Score for Neonatal Acute Physiology Perinatal Extension-II (SNAPPE-II) in predicting mortality among neonates with sepsis. Methods: A retrospective cohort analysis was conducted on 175 septic neonates admitted to the NICU. nSOFA and SNAPPE-II scores were calculated and analyzed using logistic regression and AUROC curves. Results: Both scores were significantly higher among non-survivors (p < 0.001). SNAPPE-II demonstrated a slightly superior predictive ability (AUC: 0.893) compared to nSOFA (AUC: 0.861). A moderate positive correlation (r = 0.514, p < 0.001) was observed between the two scores. Logistic regression confirmed both as independent predictors of mortality. Conclusion: While SNAPPE-II marginally outperformed nSOFA in predictive accuracy, nSOFA’s simplicity and real-time applicability render it highly valuable, particularly in resource-limited settings. Both tools offer robust risk stratification and can guide early, targeted intervention in neonatal sepsis.